PlainRecalls
FDA Drug Critical Class I Terminated

Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.

Reported: May 16, 2018 Initiated: May 1, 2018 #D-0866-2018

Product Description

Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.

Reason for Recall

Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
54,720 vials
Distribution
Nationwide in the USA and Puerto Rico
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.. Recalled by AuroMedics Pharma LLC. Units affected: 54,720 vials.
Why was this product recalled?
Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 16, 2018. Severity: Critical. Recall number: D-0866-2018.